Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis.

about

Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q43524523

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@en

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@nl

type

Item

label

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@en

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@nl

prefLabel

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@en

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@nl

P1476

Editorial: inflammation, disea ...... risk in rheumatoid arthritis.

@en

P2093

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Katherine P Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

P304

327-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/ART.38925

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25331004

http://www.w3.org/2001/XMLSchema#string

P921

inflammation